What should you know about NSC lung cancer?

Non-small cell lung cancer is a group of lung cancers that includes adenocarcinoma, squamous cell carcinoma, and other less common types. The pathology report identifies the cell pattern, while scans show the tumour’s size and whether it has reached lymph nodes or distant organs. Molecular testing may find changes that guide targeted treatment or help the team consider immunotherapy.

Symptoms vary. A persistent cough, breathlessness, chest discomfort, coughing blood, unexplained weight loss, or a hoarse voice can occur, but symptoms alone cannot identify the cancer type. Spread to the brain can cause headaches, seizures, weakness, confusion, or changes in vision.

Your team may arrange imaging, a biopsy, blood tests, and genomic tumour profiling. Treatment can involve surgery such as a lung lobectomy, radiotherapy, chemotherapy, immunotherapy, targeted medicine, or combinations. The choice depends on stage, tumour biology, lung function, symptoms, and your priorities. Ask for the pathology and staging results in plain language and keep a record of medicines and appointments.

Get emergency help for severe breathing difficulty, coughing a large amount of blood, sudden weakness, a seizure, new confusion, or a sudden change in vision or speech. Contact the treatment team promptly for fever, worsening breathlessness, chest pain, dehydration, or side effects that prevent eating or taking medicines. Palliative care can support symptoms and quality of life at any stage alongside cancer treatment.

Ask what subtype and stage the biopsy shows, whether genomic testing is needed, which treatments are suitable, how lung function affects surgery, what symptoms suggest spread, and who to call outside clinic hours.